Role of Radiotherapy Following Oesophageal Stenting in Cancer

Status Completed

Clinical Trial Summary

To assess the benefits of oesophageal stenting and external beam radiotherapy over oesophageal stenting alone in patients with inoperable oesophageal cancer

Clinical Trial Description

A majority of patients with oesophageal cancer present with inoperable disease and require rapid and long lasting palliation of dysphagia.

STUDY AIM: To compare dysphagia relief in patients treated with oesophageal stenting and external beam radiotherapy (EBRT), versus oesophageal stenting alone and to assess overall survival, treatment related complications, and quality of life in the two groups.

PATIENTS AND METHODS: Patients with inoperable oesophageal cancer with high grade dysphagia to be randomised to receive oesophageal stenting alone (Group I), versus a combination of stenting followed by EBRT (Group II). Dysphagia relief, treatment related complications, overall survival, and quality of life to be assessed in the two groups. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01179074
Study type	Interventional
Source	All India Institute of Medical Sciences, New Delhi
Contact
Status	Completed
Phase	N/A
Start date	April 2007
Completion date	March 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05685862` - Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit
Recruiting	`NCT01795768` - Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours	Phase 2
Completed	`NCT05266300` - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Recruiting	`NCT03978377` - Cardiopulmonary Toxicity of Thoracic Radiotherapy
Active, not recruiting	`NCT03653052` - Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab	Phase 2
Recruiting	`NCT04484636` - PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)	N/A
Recruiting	`NCT05489250` - The PLATON Network
Terminated	`NCT01795976` - NY-ESO-1 T Cells in OG Cancer	Phase 2
Recruiting	`NCT01843829` - A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer	Phase 2
Completed	`NCT02382237` - Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition	N/A
Completed	`NCT01915693` - ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study	Phase 3
Recruiting	`NCT04517448` - Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
Recruiting	`NCT04232735` - Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)	N/A
Recruiting	`NCT05642819` - REVOLUTION Surgery (REVOLUTION Surgery)
Recruiting	`NCT04001478` - Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
Recruiting	`NCT02741856` - Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation	Phase 2/Phase 3
Not yet recruiting	`NCT05600608` - Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome	N/A
Recruiting	`NCT04481256` - TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY	N/A
Recruiting	`NCT05057013` - HMBD-001 in Advanced HER3 Positive Solid Tumours	Phase 1/Phase 2
Not yet recruiting	`NCT06046846` - Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer	N/A